Please print out and mail to:

Christopher E. Hahn
MARF, inc.
1123 Chapala Street
2nd Floor
PO Box 91840
Santa Barbara, CA 93190-1840

or go to:

http://www.thepetitionsite.com/takeaction/698473747

and SIGN the petition


Board of Directors

M. Ann Abbe

Mathew Bergman, Esq.

Robert B. Cameron, M.D.

Michael Harbut, M.D., M.P.H.

Ulf Jungnelius, M.D.

Susan Vento

Nicholas J. Vogelzang, M.D.

Mouzetta Zumwalt-Weathers

Roger G. Worthington, Esq.

In Memoriam

Congressman Bruce F. Vento

Bill Powell

Science Advisory Board

Steven Albelda, M.D.

Raphael Bueno, M.D.

Raffit Hassan, M.D.

Steve Hahn, M.D.

Hedy Lee Kindler, M.D.

Dan Miller, M.D.

Harvey Pass, M.D., Chairman

Lary A. Robinson, M.D.

Victor Roggli, M.D.

W. Roy Smythe, M.D.

Robert N. Taub, M.D.

Joseph R. Testa, Ph.D.

Eric Vallieres, M.D.

Claire Verschraegen, M.D.

Executive Director

Christopher E. Hahn

MARF, inc.
1123 Chapala Street
2nd Floor
PO Box 91840
Santa Barbara, CA 93190-1840
tel: (805) 560-8942
fax: (805) 560-8962
http://www.marf.org

MarfPlainLogo.gif (9369 bytes)

Our Mission is to eradicate mesothelioma as a life-ending disease.

Federal Mesothelioma Research Funding Petition Statement

February 4, 2005

Mesothelioma (meso) is an asbestos-related cancer that painfully and aggressively invades the lining of the lungs, abdomen, heart or testicles. For decades, the need to develop treatments for mesothelioma was overlooked. As a result, today's standard treatments usually have only a very limited effect and the average survival time is only 4 to 14 months.

Meso kills thousands of Americans each year, and its incidence is rising. For decades asbestos was used heavily in Navy ships and shipyards, in industrial workplaces, and in the construction of our buildings, schools, and homes. Meso has a long latency (30 years average) and most at risk are millions of U.S. workers and servicemen who were exposed almost daily over long periods of time. When they brought the fibers home each night on their hair, skin and clothes, their wives and children were exposed too.

But even short-term, low exposures can cause the disease, and Americans continue to be put at risk today. The EPA estimates that asbestos is present in as many as 30 million U.S. homes. It still has not been banned in the U.S. and is used in over 3,000 products. Hundreds of tons were released into New York's air from the collapse of the World Trade Center on 911. At least 100,000 firefighters, police officers, rescue workers and New York City residents, workers and school children were likely exposed to dangerous levels.

Therefore, to limit future suffering and death caused by meso, The Mesothelioma Applied Research Foundation recommends the establishment of a National Mesothelioma Research and Treatment Program (NMRTP), federally funded at $30 million per year. Experts believe that with appropriate resources, effective means to treat meso, and/or to detect it early and prevent it, are within reach. Currently, there are no federal dollars specifically allocated for mesothelioma research, even though one third of mesothelioma patients were exposed in U.S. Navy ships and shipyards.

The NMRTP would function primarily through ten mesothelioma centers located strategically throughout the country. The NMRTP's first priority would be to move forward on exciting advances being made in early detection and prevention.

The second priority would be research to improve treatments for, and ultimately cure, mesothelioma. This includes all of the novel surgical, chemotherapeutic, radiation, and biologic strategies now being pursued. It also includes a registry and tissue bank. Unlike most European nations, the U.S. does not maintain a comprehensive registry for mesothelioma as a reportable disease.

The final priority is education. Public awareness of mesothelioma must increase. More young investigators and clinicians must be trained. Meso patients, their family members and their local physicians need accessible, up-to-date information on newly available treatments, on managing pain and side effects, and on coping with this cruel disease.

My signature below indicates that I support The Mesothelioma Applied Research Foundation's work to establish a National Mesothelioma Research and Treatment Program, federally funded at $30 million per year.

___________________________________________________________ __________________
[name] [date]
________________________________________________________________________________
[street number, city and state]


*** POSTED FEBRUARY 4, 2005 ***